Cyclic RGD modified Lipopolymeric Nanoparticles for Targeted Delivery of Tamoxifen in ER plus Breast Cancer

Abstract

newline

Description

Keywords

Citation

Collections

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced